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ABSTRACT
Background and Aim: Type II Diabetes is the most common diseases of metabolic disorders and the 
treatment of oral anti-diabetic drug use takes place But The problem of using multi-drug and interactions 
at the same time is an issue that has always been a major challenge And diagnosis of drug interactions, 
particularly in Diabetic patients due to the problem with the disease is very important. The purpose 
of this studying is, to design a clinical assistant decided to use this approach to determine the type II 
diabetes drug interactions this makes it easy for those who are active in the field. Materials and Methods: 
Study is Developmental that to determine the content of the system a self-made checklist was used. 
Checklist Validity and reliability has been confirmed by four professors. The Research community to 
determine the content of the system was country endocrine that are 124 people.  The sample size was 
calculated using Cochran that was 57 people. The Score of checklist was calculated in SPSS version 20 
.finally, the checklist was approved by at least 70% points. The system by using Microsoft SQL server 
2008 and visual Studio 2012 development environment was designed in C#.net. In the end, In order to 
evaluate the software to determine the level of satisfaction, usability and ease of use, designed systems 
sharing with all Medical Informatics students of Tehran University of Medical Sciences. For this purpose 
a self-made questionnaire was used. Questionnaire Validity has been confirmed by four professors 
and reliability was assessed by Cronbach method. Results: The results of the survey are showing that 
the majority of students found out and believed the software is useful and easy to use and generally 
expressed their satisfaction software. Conclusions: The methodology provides a suitable approach for 
analysis and modeling of data in the medical field and the performance is good.
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1. INTRODUCTION
Diabetes is a chronic disease in which 
blood sugar levels are too high and in-
sulin secreted by the pancreas, the body 
cannot properly use (1, 2). The number 
of people with diabetes worldwide in 
2008 was 230 million and is expected 
to reach 300 million people by 2025, 
the number of people with diabetes (3, 
4, 5).
In Iran, the head of non-communi-
cable diseases is diabetes (5, 6). About 
90% of all people with diabetes have 
type II diabetes. Type II diabetes oc-
curs in people over 30 years and 
through diet and exercise properly 
treated. In addition, this type of dia-
betes treatment used oral anti-diabetic 
medicines (2, 7, 8). Drug therapy is 
one of the most common methods of 
treatment. Prescribing the correct and 
proper use of drugs is an important 
factor in public health security pro-
vider (9). The simultaneous use of sev-
eral drugs in the treatment of patients 
is increased (10). Medication errors are 
the most important medical error and 
Drug interactions in the prescription 
drug is considered as one of the main 
errors (11). Since the treatment of dia-
betic patients with oral anti-diabetic 
drugs played and People with diabetes 
are often people over 30 years. There-
fore, their risk for comorbidities such 
as heart disease - cardiovascular, blood 
pressure, nerve damage, kidney dis-
ease and do not skimp. It also follows 
that the treatment of diabetes compli-
cations, they need to take medicine. So 
often patients with Type II diabetes for 
life must take several drugs simulta-
neously (12). Therefore, it is necessary 
to somehow prevent drug interactions 
between anti-diabetic drugs and other 
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drugs seized.
Today, IT is entered in all social contexts, and all sciences 
and is growing rapidly. IT increasingly is used in modern 
medical practices, health care management and medical pro-
fessional knowledge. One of the sections related to artificial 
intelligence is decision support systems that play a major role 
in this area. One of the areas that decision support systems is 
entered in is the healthcare field (13, 14, 15). Clinical decision 
support systems are interactive computer programs that are 
designed for helping doctors and other health professionals to 
deciding task (16, 17). All the evidence indicates that a deci-
sion support system to evaluate drug interactions diabetes is 
required. Help doctors in diagnosing drug interactions to re-
duce the side effects and cost of drug interactions in the field 
of diabetes and patients are affected less damage. Considering 
the results shorts Leaf and colleagues at providing decision 
support system for diagnostic and therapeutic applications 
called Mysyn and its success as well as the implementation of 
these systems worldwide (18) and according to the need that 
is felt in the field of drug interactions with type 2 diabetes, 
this research uses design techniques to design and implement 
clinical decision support system in this area.
2. METHODS
This study is development type that at first the necessary 
knowledge in the field of diabetes type II, type II diabetes 
treatments, drugs and their interactions through various such 
as consultation with experts in endocrine diseases fields, ref-
erence books, articles and valid databases are achieved. Then 
the knowledge base file Created and knowledge derived in the 
previous steps in the encrypted and understandable form was 
stored for system. The user interface was designed by using C 
# .net language in Visual Studio 2012. The user interface is a 
set of equipment and software that acts as a communication 
channel between user and expert system. In fact, this allows 
the user to enter information related desired problem into 
the system on the other hand gives CONCLUSIONS system 
to user. Finally, the evaluation of the whole system was per-
formed by questionnaire was built by the researcher.
The questionnaire was designed to evaluate the useful-
ness, ease of use and satisfaction of software (Table 1). That 
is consist of 13 questions. Scoring it based on the Likert scale 
ranged from 5 options strongly agree, agree, neutral, disagree 
and strongly disagree was set and to Responses from strongly 
disagree to strongly agree 1 to 5 grades were considered. Be-
cause of these systems are in the field of medical informatics 
students so for survey software, from Students of Tehran 
University of Medical Informatics requesting to cooperation 
and the results were inserted in SPSS software.
3. RESULTS
In this study, 20 questionnaires were distributed, after 
completed the data were entered into SPSS software version 
21. The results of this questionnaire in the form of the table 
following below.
4. DISCUSSION
For designing Knowledge Base for Type 2 diabetes drug 
interaction detection system, Microsoft SQl Server R2 is 
used. This Database is formed of 4 tables to store and keep 
The questions











It makes the things I want 
to accomplish easier to 
get done
3 15% 17 85% - - - - - -
It saves me time when I 
use it. 5 25% 15 75% - - - - - -
It does everything I would 
expect it to do. - - 4 20% 3 15% 13 65% - -
In terms of appearance 
(color combinations, font, 
icon)it is Appropriate
18 90% 2 10% - - - - - -
It requires the fewest 
steps possible to accom-
plish what I want to do 
with it.
17 85% 3 15% - - - - - -
I can use it without 
written instructions 19 95% 1 5% - - - - - -
There is no contradiction 
and incompatibility when 
using it
17 85% 3 15% - - - - - -
I can use it successfully 
every time - - 5 25% 1 5% 14 70% - -
I learned to use it quickly 18 90% 2 10% - - - - - -
I am satisfied with the 
speed of execution soft-
ware and data entry
19 95% 1 5% - - - - - -
I would recommend it to 
a friend 17 85% 2 10 1 5% - - - -
It works the way I want it 
to work. 2 10% 18 90% - - - - - -
I can recover from mis-
takes quickly and easily.  18 90% 2 10% - - - - - -
Table 1. The questionnaire designed to evaluate the usefulness, ease of use and satisfaction of software.
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name of antidiabetic drugs and conflicted drugs with them, 
identify drug interactions between the two drugs, the phar-
maceutical groups and interactions between them. Designing 
this system is simple and quick. Because of the importance of 
this issue (Diagnosis of type 2 diabetes drug interactions) the 
implementation is based on rule-based model was performed. 
Often clinical decision support system based on fuzzy or 
neural network are designed and implemented in MATLAB 
environment. MATLAB development environment has a 
fundamental flaw and it is that interpretation language. As a 
result, the speed of execution of this is very slower than com-
piled languages such as C # .NET and tedious (19).
In this study without the use of complex models such as 
neural networks and fuzzy systems or Using MATLAB envi-
ronment, a simple model based on rules and C # .NET pro-
gramming language compiler was used. It can be stated with 
simple models and fast programming languages such as C # 
.NET can also design decision support systems that the appli-
cation of high and good results have followed.
5. CONCLUSION
Although the interaction of drugs on each other in most 
cases have little importance and may even be useful. But 
many drug interactions may lead to undesirable and some-
times life-threatening reactions. Obviously aware of Phar-
macology and understanding mechanisms underlying drug 
interactions Many drug interactions are predictable and can 
be prevented from occurring, many of them (20).
So that, decision support systems should be designed they 
can examine drug interactions of various diseases. These sys-
tems cause drug interactions Statistics reduced, resulting in 
injuries or deaths resulting from it reduced interference.
In the present study designed system with a capacity to 
evaluate drug interactions with other medications can re-
duce type 2 diabetes medication errors, reduce costs associ-
ated with adverse drug events, improve quality and improve 
the health.
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